Welcome to our dedicated page for DocGo news (Ticker: $DCGO), a resource for investors and traders seeking the latest updates and insights on DocGo stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DocGo's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DocGo's position in the market.
Rhea-AI Summary
DocGo Inc. (Nasdaq: DCGO) will announce its first quarter 2024 financial results on May 8, 2024. The company, a leading provider of technology-enabled mobile health services, will host a conference call and webcast to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.68%
Tags
-
News
Rhea-AI Summary
DocGo Inc. (DCGO) extends migrant services contract with NYC Department of Housing Preservation and Development, showcasing continued partnership and commitment to quality services. The extension runs through 2024, allowing DocGo to focus on growth initiatives and partnerships.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.99%
Tags
-
Rhea-AI Summary
New York City FC and DocGo (Nasdaq: DCGO) have announced a partnership to make Ambulnz by DocGo an Official Partner of New York City FC. Ambulnz will provide event medical services at NY City FC events and community initiatives, with brand visibility at MLS home matches. The collaboration aims to promote healthier lives through soccer.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.69%
Tags
Rhea-AI Summary
DocGo Inc. (Nasdaq: DCGO) announces leadership members' recent share purchases, showing confidence in the company's future. Norman Rosenberg, DocGo CFO, bought 10,000 shares at $3.61 each; Steven Katz, incoming Chair of the Board, acquired 13,500 shares at $3.64; Michael Burdiek, Board member, purchased 10,000 shares at $3.61. CEO Lee Bienstock highlights belief in DocGo's strong fundamentals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.71%
Tags
-
Rhea-AI Summary
DocGo Inc. (Nasdaq: DCGO) has repurchased 1.25 million shares of its common stock at $3.88 per share under its $36 million Repurchase Program. The company also initiated a 10b5-1 trading plan to repurchase an additional $10 million of its stock, aiming to create shareholder value and sustain profitable growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.71%
Tags
-
Rhea-AI Summary
DocGo Inc. updates 2024 revenue guidance to $720-$750 million and introduces adjusted EBITDA guidance of $80-$85 million. The company reports strong financial performance for Q4 2023 with total revenues of $199.2 million, a year-over-year increase of 83%. Net income for Q4 2023 was $8.0 million, up by 13%. Adjusted EBITDA for Q4 2023 saw a significant increase of 232% to $22.6 million. Full-year 2023 revenues reached $624.2 million, a 42% increase over 2022. However, net income for 2023 decreased to $10.0 million due to non-cash, stock-based compensation and an income tax provision. The company's cash and cash equivalents stood at $72.2 million as of December 31, 2023, with additional payments of $120 million received in 2024. DocGo also announced various corporate highlights and initiatives, including a share repurchase program.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.3%
Tags
Rhea-AI Summary
DocGo Inc. (DCGO) hires Jen McLean and Yong Kim as Vice Presidents to expand health plan partnerships and government programs. Kim brings experience from CVS Health, focusing on business growth and value-based care. McLean, from City Harvest, will lead public health initiatives. DocGo aims to democratize healthcare through innovative technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.71%
Tags
-
Rhea-AI Summary
DocGo Inc. (Nasdaq: DCGO) to release financial results for Q4 and full year 2023 on February 28, 2024. Management to host conference call and webcast to discuss results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.96%
Tags
-
Rhea-AI Summary
DocGo Inc. (Nasdaq: DCGO) will be participating in investor conferences in February and March, including the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference and the 44th Annual Health Care Conference. The company will engage in 1x1 investor meetings at both events, providing an opportunity for networking and potential investment opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.65%
Tags
Rhea-AI Summary
DocGo Inc. (Nasdaq: DCGO) has announced a new share repurchase program allowing the purchase of up to $36 million of its common stock by July 30, 2024. The prior share repurchase authorization expired on November 24, 2023. The approved amount represents approximately 10% of DocGo’s outstanding shares based on the share price at the time of authorization. The company may purchase shares through open market repurchases, privately negotiated transactions, or other means. The timing and actual number of shares repurchased will depend on various factors, including stock price, trading volume, and market conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.5%
Tags
DocGo Inc.
Nasdaq:DCGO
DCGO Rankings
DCGO Stock Data
358.12M
82.24M
11.33%
54.21%
10.07%
Dental Laboratories
Manufacturing
United States of America
NEW YORK
About DCGO
DocGo is a leading provider of mobile medical services and transportation in 26 US States and in the United Kingdom.